153 related articles for article (PubMed ID: 7000494)
21. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
22. Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice.
Flatt PR; Bailey CJ; Kwasowski P; Page T; Marks V
J Endocrinol; 1984 Jun; 101(3):249-56. PubMed ID: 6374002
[TBL] [Abstract][Full Text] [Related]
23. Acid-induced gastric inhibitory polypeptide secretion in man.
LeRoith D; Spitz IM; Ebert R; Liel Y; Odes S; Creutzfeldt W
J Clin Endocrinol Metab; 1980 Dec; 51(6):1385-9. PubMed ID: 7002949
[TBL] [Abstract][Full Text] [Related]
24. Influence of gastric inhibitory polypeptide antiserum on glucose-induced insulin secretion in rats.
Ebert R; Creutzfeldt W
Endocrinology; 1982 Nov; 111(5):1601-6. PubMed ID: 6751797
[TBL] [Abstract][Full Text] [Related]
25. Gastric inhibitory polypeptide hypersecretion in diabetes mellitus: effect of sulfonylurea treatment.
Coxe JS; O'Dorisio TM; Cataland S; Crockett SE
J Clin Endocrinol Metab; 1981 May; 52(5):1002-5. PubMed ID: 7014585
[TBL] [Abstract][Full Text] [Related]
26. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.
Lauritsen KB; Moody AJ; Christensen KC; Lindkaer Jensen S
Scand J Gastroenterol; 1980; 15(7):833-40. PubMed ID: 7010526
[TBL] [Abstract][Full Text] [Related]
27. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
28. The role of endogenous gastric inhibitory polypeptide in the enteroinsular axis.
Takemura J; Seino Y; Yamamura T; Tsuda K; Seino S; Itoh N; Imura H
J Clin Endocrinol Metab; 1982 May; 54(5):909-13. PubMed ID: 7037822
[TBL] [Abstract][Full Text] [Related]
29. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats.
Ebert R; Illmer K; Creutzfeldt W
Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554
[TBL] [Abstract][Full Text] [Related]
30. Insulin and gastric inhibitory polypeptide secretion in young milk-fed and adult goats.
Nilssen KJ; Hove K; Jorde R
Am J Physiol; 1983 Mar; 244(3):E209-15. PubMed ID: 6338735
[TBL] [Abstract][Full Text] [Related]
31. Functional enteroinsular axis in full-term newborn infants.
King KC; Oliven A; Kalhan SC
Pediatr Res; 1989 May; 25(5):490-5. PubMed ID: 2497435
[TBL] [Abstract][Full Text] [Related]
32. Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss.
Jones IR; Owens DR; Luzio SD; Hayes TM
Diabete Metab; 1989; 15(1):11-22. PubMed ID: 2721810
[TBL] [Abstract][Full Text] [Related]
33. The effect of massive small bowel resection (MSBR) and small intestinal bypass (JIB) in the rat on the enteroinsular axis.
Buchan AM; Pederson RA; Chan CB; Brown JC
Regul Pept; 1983 Nov; 7(3):221-32. PubMed ID: 6364262
[TBL] [Abstract][Full Text] [Related]
34. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
Reynolds C; Tronsgard N; Gibbons E; Blix PM; Rubenstein AH
J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
[TBL] [Abstract][Full Text] [Related]
35. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
[TBL] [Abstract][Full Text] [Related]
36. Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.
Sarson DL; Kopelman PG; Besterman HS; Pilkington TR; Bloom SR
Diabetologia; 1983 Nov; 25(5):386-91. PubMed ID: 6360777
[TBL] [Abstract][Full Text] [Related]
37. Similar plasma GIP responses in obese and lean subjects after an oral test meal and after intraduodenal stimulation with fat and glucose.
Amland PF; Jorde R; Burhol PG; Giercksky KE
Int J Obes; 1984; 8(6):649-53. PubMed ID: 6398318
[TBL] [Abstract][Full Text] [Related]
38. The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients.
Lauritsen KB; Frederiksen HJ; Uhrenholdt A; Holst JJ
Scand J Gastroenterol; 1982 Jun; 17(4):513-6. PubMed ID: 6753108
[TBL] [Abstract][Full Text] [Related]
39. Increased plasma response of gastric inhibitory polypeptide to oral glucose and a liquid meal after prolonged starvation in healthy man.
Oektedalen O; Opstad PK; Jorde R
Digestion; 1983; 26(3):114-23. PubMed ID: 6343163
[TBL] [Abstract][Full Text] [Related]
40. Glucose-dependent insulin-releasing peptide in noninsulin-dependent maturity-onset diabetes: effects of autonomic neuropathy.
Levitt NS; Vinik AI; Child PT
J Clin Endocrinol Metab; 1980 Aug; 51(2):254-8. PubMed ID: 6995476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
